The diagnosis fits neatly into a press release and MAGA arguments about elite institutions gone rotten.
That diagnosis is that UCLA admitted Black and Hispanic medical students with lower test scores than Asian and white students. There it is. The DEI scandal in plain sight.
But medicine has a habit of ruining clean political arguments. A patient is not a standardized test. A doctor’s job is not only to know the answer, but to make another human being—frightened, suspicious or ashamed—willing to act on it.
That is why President Donald Trump’s Justice Department has found an unusually potent target in UCLA’s David Geffen School of Medicine, and also an unusually dangerous one. The government’s case may expose a real admissions abuse. It may also expose something MAGA does not want to admit: “merit” is not as simple as the highest score in the pile.
UCLA is now the latest front in the administration’s broader fight with universities, a fight that has already pulled the school into a larger federal standoff and turned higher education into one of the culture war’s most intense battlegrounds. But this one is different. This is not just about who gets admitted. It is about how admissions affect patients.
UCLA And The Numbers MAGA Wanted
The immediate facts make this case politically explosive. In its findings letter, the Justice Department says UCLA admitted Black and Hispanic students in 2023 with median Medical College Admission Test scores of 507, the 68th percentile, while admitted Asian and white students had median scores of 514, the 88th percentile. In 2024, admitted Hispanic students had a median MCAT of 506, the 66th percentile, while admitted Asian students had 515, the 90th percentile.
Those numbers are, in one sense, alarming. Pretending otherwise is an insult to every applicant who studied, paid, retook, worried and lost. If UCLA used race as race after the Supreme Court’s affirmative action ruling, then it has a serious legal problem.
But the numbers also contain complications that MAGA would rather ignore. A 506 or 507 is not a sign of incompetence, though clearly it is a sign of inferior test performance. According to DOJ’s own presentation, those scores were still above most test-takers. So the question is not only whether UCLA was letting less qualified people into medicine. The question is whether American medicine has mistaken one measurable kind of merit for the whole thing—and whether that really represents justice.
The Justice Department’s Argument Against UCLA
The government’s case is serious. That is what makes the politics of it more dangerous, not less.
DOJ says UCLA used holistic review to discover and then use applicants’ race through secondary essays, interviews and admissions committees. It also says UCLA embraced the “dubious contention” that patients receive the best care from doctors of the same race “rather than by the most qualified.”
That is the anti-DEI argument in one sentence. It is emotionally powerful because it tells Asian and white applicants that the system cheated them, and tells patients they are being used as political test cases.
UCLA’s defense is that its admissions process is “based on merit” and committed to state and federal law, according to The Associated Press. That answer may be true but also too narrow. The legal test after Students for Fair Admissions is clear: universities may consider how a life shaped an applicant, but they may not use essays as a way to get around the affirmative action ruling. Chief Justice John Roberts put the limit plainly: students must be treated according to experiences “as an individual—not on the basis of race.”
If UCLA crossed that line, it should lose. No one should have to compete for a medical school seat against an invisible racial target.
A Bedside Problem Critics Can’t Score
Yet the Justice Department’s framing has its own problem. It assumes the “most qualified” doctor is always the one who won the pre-admission scoreboard. Medicine is not always so obedient.
A doctor can be brilliant on paper and still fail in the job. A patient can hear correct advice and refuse the test. A physician can know every guideline, order every screening, recite every risk factor and still fail at the human transaction that turns medical expertise into medical action. That is not irrelevant. It is the essence of care.
The strongest pro-diversity argument is not the lazy one that scores do not matter. It is that scores measure only part of what a doctor must be. In the exam room, trust can be the difference between treatment and avoidance.
This is where Trump’s war on DEI starts to backfire. It may expose a real admissions abuse. But it also exposes how small the MAGA definition of merit becomes when patients enter the story.
Lessons From Oakland
The most provocative evidence comes from Oakland. In a major American Economic Review study, researchers randomly assigned Black men to Black or non-Black male doctors. Before meeting the doctor, patients chose similar amounts of preventive care. After the meeting, the authors wrote, patients were “much more likely to select every preventive service” when they met a racially concordant doctor, especially for more invasive services. The authors estimated that Black doctors could reduce the Black-white male cardiovascular mortality gap by 19 percent.
The effect is concentrated where trust matters most: decisions that require patients to accept something uncomfortable, invasive or frightening.
There is, potentially, a hard truth here for the anti-DEI side. If one doctor is more likely to persuade a patient to accept preventive care, then in that specific context the doctor may be more effective, regardless of test scores. And effectiveness is supposed to be part of merit.
What The Science Actually Shows
The science does not give UCLA a blank check.
The Oakland study is strong because of its design, but it studied Black men in one city and one kind of preventive-care encounter. It does not prove that racial matching should govern medical admissions. It does not prove that Hispanic patients need Hispanic doctors, or that white patients need white doctors, or that every form of racial concordance improves outcomes.
Still, Oakland is not alone. A National Bureau of Economic Research paper using the Military Health System found racial concordance was linked to “improved maintenance of preventive care” and lower mortality among Black patients with chronic, manageable diseases. The later journal version, published in the Review of Economic Studies, reported that a one-standard-deviation increase in exposure to Black providers was associated with an 18 percent relative decline in Black mortality compared with non-Black mortality among those patients.
A JAMA Network Open study of 117,589 patient surveys found that higher Press Ganey survey scores—a measure of patient experience and satisfaction—were associated with racial and ethnic concordance between patients and physicians. In other words, patients in racially or ethnically discordant pairings were less likely to give the maximum patient-experience score.
All this needs a warning label. Some findings are observational. Some are about satisfaction rather than survival. Some cannot cleanly separate race, language, class, hospital quality, geography and prior experience with the health system. A review protocol on the subject noted that two decades of concordance research had produced “contradictory results.”
It is a headache. The evidence is certainly not strong enough to justify racial discrimination, but it is also too strong to justify MAGA’s sneer that the whole thing is fake.
The Anti-DEI Side Has A Point
The critics deserve their strongest case. Groups such as Do No Harm, which says it is focused on keeping identity politics out of medicine, argue that “mission-aligned” selection can become a convenient shield for race-based admissions by another name. In a recent critique, the group said the Association of American Medical Colleges’ language could offer a “fig leaf” to schools engaged in ideological or racial admissions policies.
That worry is not paranoid. Once admissions committees are told to value mission, community, context and lived experience, some will do the work carefully, and others will not. The AAMC says mission-aligned selection considers “test scores, grades, experiences, and applicant context” to identify applicants likely to thrive and contribute to a program’s goals and the practice of medicine. In careful hands, that is common sense. In ideological hands, it can become laundering.
The same goes for racial-concordance research. The often-cited PNAS study on Black newborns and Black physicians suggested major mortality benefits, but subsequent critics argued that controlling for very low birth weight sharply weakened or eliminated the effect. That does not destroy the Oakland study. It does warn against building a racial admissions regime on a handful of headline-grabbing papers.
Medical schools should not use patient-trust research as a permission slip for racial preference. That would be both legally reckless and intellectually lazy.
But the anti-DEI side has its own myth: that objectivity lives only in numbers.
Medical Merit Is Not A Scantron
The MCAT—the standardized exam used by medical schools to assess applicants’ readiness for medical training—is useful. GPA is useful. Medical schools should care about both. Patients should not become the final exam for social theories that admissions offices wish were true. Nobody wants a cardiologist selected because the committee liked a paragraph about adversity more than evidence of academic discipline.
But nobody should want the opposite stupidity either: a system that treats test-score deltas as if they settle who will heal best.
The MCAT predicts some academic outcomes. It does not fully predict who will serve rural communities, who will stay in primary care, who will listen well, who will communicate across distrust, who will catch the unspoken symptom, who will keep a vulnerable patient coming back.
Medicine is full of people who can pass tests. It is not full enough of people who can get patients to accept care before catastrophe arrives.
MAGA wants merit to be simple because simplicity wins arguments. Medicine makes it complicated because patients are complicated.
The Real UCLA Lesson: It’s Complicated
The right legal answer may be that UCLA cannot do what DOJ says it did. The right medical answer may be that DOJ’s definition of merit is dangerously incomplete. Both can be true. That is what makes the UCLA case more than another entry in Trump’s endless culture wars.
If UCLA treated race as a plus factor, it should be stopped. If applicants were denied because they were Asian or white, that is discrimination. No euphemism about mission, equity or representation should obscure that.
But if MAGA uses the case to pretend that a doctor is only the sum of MCAT percentile, GPA and ideological compliance with colorblind rhetoric, it will have learned the wrong lesson. The bedside is a cruel place for slogans. It asks only what works.
Patients do not experience care as a spreadsheet. They experience it as fear, trust, confusion, shame, pain and decisions made under pressure. The best doctor is not always the applicant with the highest score.
That complication is a bitter pill for all sides to swallow. The case against UCLA may yet be legally correct. The war on DEI may still backfire at the bedside.
Related Articles
